Lymphatica is a medical device development company that has designed and patented LymphoDrain, a novel implantable system replacing lymphatic vessel draining function. The system is based on magnetically controlled micropumps, and it has been conceived to treat chronic lymphedema, a common side effect of cancer therapies. Currently there is no cure for lymphedema. LymphoDrain represents the first effective solution for more than 10 million lymphedema patients in EU and United States.

2017 Switzerland Gold Winner